Dan Yrigoyen - Nov 10, 2022 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTH)

Signature
/s/ Dan Yrigoyen
Stock symbol
ARTH
Transactions as of
Nov 10, 2022
Transactions value $
$0
Form type
4
Date filed
11/10/2022, 08:50 PM
Previous filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTH Stock Option (right to buy) Award $0 +500K $0.00 500K Nov 10, 2022 Common Stock 500K $0.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.